| Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer BT Li, EF Smit, Y Goto, K Nakagawa, H Udagawa, J Mazières, ... New England Journal of Medicine 386 (3), 241-251, 2022 | 552 | 2022 |
| Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial BC Creelan, C Wang, JK Teer, EM Toloza, J Yao, S Kim, AM Landin, ... Nature medicine 27 (8), 1410-1418, 2021 | 215 | 2021 |
| Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC): Interim results of DESTINY-Lung01. EF Smit, K Nakagawa, M Nagasaka, E Felip, Y Goto, BT Li, JM Pacheco, ... Journal of Clinical Oncology 38 (15_suppl), 9504-9504, 2020 | 138 | 2020 |
| Update on the biology, management, and treatment of small cell lung cancer (SCLC) A Saltos, M Shafique, A Chiappori Frontiers in oncology 10, 1074, 2020 | 114 | 2020 |
| Phase I/Ib study of pembrolizumab plus vorinostat in advanced/metastatic non–small cell lung cancer JE Gray, A Saltos, T Tanvetyanon, EB Haura, B Creelan, SJ Antonia, ... Clinical Cancer Research 25 (22), 6623-6632, 2019 | 112 | 2019 |
| OA04. 05 trastuzumab deruxtecan in HER2-overexpressing metastatic non-small cell lung cancer: interim results of DESTINY-Lung01 K Nakagawa, M Nagasaka, E Felip, J Pacheco, C Baik, Y Goto, A Saltos, ... Journal of Thoracic Oncology 16 (3), S109-S110, 2021 | 69 | 2021 |
| Ambulatory cell phone injuries in the United States: an emerging national concern DC Smith, KM Schreiber, A Saltos, SB Lichenstein, R Lichenstein Journal of safety research 47, 19-23, 2013 | 65 | 2013 |
| Long-term outcome of Gamma Knife stereotactic radiosurgery for arteriovenous malformations graded by the Spetzler-Martin classification MT Koltz, AJ Polifka, A Saltos, RG Slawson, Y Kwok, EF Aldrich, ... Journal of Neurosurgery 118 (1), 74-83, 2013 | 60 | 2013 |
| Prospective single-arm phase 1 and 2 study: ipilimumab and nivolumab with thoracic radiation therapy after platinum chemotherapy in extensive-stage small cell lung cancer BA Perez, S Kim, M Wang, AM Karimi, C Powell, J Li, TJ Dilling, ... International Journal of Radiation Oncology* Biology* Physics 109 (2), 425-435, 2021 | 34 | 2021 |
| Abstract CT056: Durable complete responses to adoptive cell transfer using tumor infiltrating lymphocytes (TIL) in non-small cell lung cancer (NSCLC): A phase I trial B Creelan, C Wang, J Teer, E Toloza, J Mullinax, J Yao, J Koomen, S Kim, ... Cancer research 80 (16_Supplement), CT056-CT056, 2020 | 24 | 2020 |
| Locally advanced, unresectable non-small cell lung cancer S Puri, A Saltos, B Perez, X Le, JE Gray Current oncology reports 22, 1-10, 2020 | 24 | 2020 |
| Clinical associations of mucin 1 in human lung cancer and precancerous lesions A Saltos, F Khalil, M Smith, J Li, M Schell, SJ Antonia, JE Gray Oncotarget 9 (86), 35666, 2018 | 23 | 2018 |
| Cell-phone related injuries in the United States from 2000–2012 A Saltos, D Smith, K Schreiber, S Lichenstein, R Lichenstein Journal of safety studies 1 (1), 1-14, 2015 | 20 | 2015 |
| Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer S Niyongere, A Saltos, JE Gray Journal of Thoracic Disease 10 (Suppl 3), S433, 2018 | 17 | 2018 |
| Pathology issues in thoracic oncology: histologic characterization and tissue/plasma genotyping may resolve diagnostic dilemmas I Dagogo-Jack, A Saltos, AT Shaw, JE Gray American Society of Clinical Oncology Educational Book 37, 619-629, 2017 | 10 | 2017 |
| Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC). AN Saltos, T Tanvetyanon, BC Creelan, MR Shafique, SJ Antonia, ... Journal of Clinical Oncology 38 (15_suppl), 9567-9567, 2020 | 9 | 2020 |
| Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy K Turner, NC Brownstein, Z Thompson, I El Naqa, Y Luo, HSL Jim, ... Radiotherapy and Oncology 167, 116-121, 2022 | 8 | 2022 |
| Breaking the impasse: advances in treatment of small cell lung cancer A Saltos, S Antonia Clinics in Chest Medicine 41 (2), 269-280, 2020 | 8 | 2020 |
| Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC). AN Saltos, T Tanvetyanon, CC Williams, EB Haura, BC Creelan, ... Journal of Clinical Oncology 36 (15_suppl), 9046-9046, 2018 | 8 | 2018 |
| P76. 62 RAMOSE: an open-label randomized phase II study of osimertinib with or without ramucirumab in TKI-naïve EGFR-mutant metastatic NSCLC A Saltos, C Baik, RE Sanborn, E Shum, C Kim, R Hall, MJ Fidler, CA Shu, ... Journal of Thoracic Oncology 16 (3), S614, 2021 | 7 | 2021 |
